Who owns Contineum Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CTNM from SEC Form 13F filings across 118 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 118 institutions disclosed 34.4M shares of Contineum Therapeutics, Inc. worth $455.3M — about 89.6% of shares outstanding; the largest disclosed holder is MONTANOVA CAPITAL, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
118
13F holders
$455.3M
value, 2026 filers
89.6%
of shares outstanding (34.4M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CTNM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 2.8M | $37.8M | 0.9% | 7.3% | -0.9% |
| 2 | FMR LLC | 2.6M | $35.0M | 0.0% | 6.8% | +151.0% |
| 3 | BlackRock, Inc. | 2.2M | $29.8M | 0.0% | 5.8% | +7.7% |
| 4 | JOHNSON & JOHNSON | 2.0M | $26.6M | 3.5% | 5.2% | 0.0% |
| 5 | Janus Henderson Group Ltd.NEW | 1.7M | $23.1M | 0.0% | 4.5% | new |
| 6 | FRANKLIN TEMPLETON INC | 1.7M | $16.7M | 0.0% | 4.4% | -7.3% |
| 7 | Balyasny Asset Management L.P. | 1.7M | $22.7M | 0.0% | 4.4% | +11.3% |
| 8 | Trails Edge Capital Partners, LPNEW | 1.7M | $22.7M | 3.3% | 4.4% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $18.3M | 0.0% | 3.5% | +3.1% |
| 10 | Versant Venture Management, LLC | 1.3M | $17.3M | 15.9% | 3.4% | +138.2% |
| 11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.1M | $15.1M | 0.0% | 2.9% | +243.0% |
| 12 | STATE STREET CORP | 808,514 | $10.9M | 0.0% | 2.1% | +89.8% |
| 13 | MILLENNIUM MANAGEMENT LLC | 775,324 | $10.4M | 0.0% | 2% | -16.8% |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 764,111 | $10.3M | 0.0% | 2% | +10.2% |
| 15 | GOLDMAN SACHS GROUP INC | 753,900 | $10.1M | 0.0% | 2% | +51.6% |
| 16 | NOVO HOLDINGS A/SNEW | 704,013 | $9.4M | 0.6% | 1.8% | new |
| 17 | SECTORAL ASSET MANAGEMENT INC | 689,587 | $9.3M | 5.9% | 1.8% | -5.2% |
| 18 | HHLR ADVISORS, LTD. | 669,337 | $9.0M | 0.6% | 1.7% | 0.0% |
| 19 | RED TREE MANAGEMENT, LLC | 638,158 | $8.6M | 7.3% | 1.7% | 0.0% |
| 20 | Longaeva Partners L.P. | 625,737 | $8.4M | 0.2% | 1.6% | -23.0% |
| 21 | Ikarian Capital, LLC | 594,666 | $8.0M | 0.8% | 1.5% | -26.4% |
| 22 | Boxer Capital Management, LLC | 494,000 | $6.6M | 0.6% | 1.3% | 0.0% |
| 23 | ADAR1 Capital Management, LLC | 384,890 | $5.2M | 0.2% | 1% | +38.0% |
| 24 | Integral Health Asset Management, LLCNEW | 345,000 | $4.6M | 0.3% | 0.9% | new |
| 25 | Squadron Capital Management LLC | 323,570 | $4.3M | 1.1% | 0.8% | +24.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.